Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Smoldering Multiple Myeloma × Myelography × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vomiting 1 Smoldering Multiple Myeloma 1 Psychomotor Agitation 1 Pain, Postoperative 1

Interventions

Lenalidomide 16 Dexamethasone 13 Calcium Dobesilate 7 daratumumab 5 carfilzomib 4 Melphalan 4 dexamethasone acetate 3 dexamethasone 21-phosphate 3 auricularum 3 Curcumin 3 elotuzumab 2 Peripheral Blood Stem Cell Transplantation 2 PVX-410 vaccine 2 Leflunomide 2 Denosumab 2 Cyclophosphamide 2 Bortezomib 2 siltuximab 1 selinexor 1 sargramostim 1 pomalidomide 1 poly ICLC 1 piperine 1 pembrolizumab 1 ixazomib 1 isatuximab 1 ibrutinib 1 iberdomide 1 fludarabine phosphate 1 fludarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04144387 2024-03-06

CARRISMM

Intergroupe Francophone du Myelome

Phase NA Active not recruiting

Smoldering Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡